{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:53:19Z","timestamp":1792176799333,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.neurobiolaging.2013.06.018","type":"journal-article","created":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T12:17:01Z","timestamp":1376569021000},"page":"143-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"title":["Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia"],"prefix":"10.1016","volume":"35","author":[{"given":"Paula T.","family":"Trzepacz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kory","family":"Schuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Case","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Hochstetler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Hake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib1","unstructured":"Alzheimer's Association. 2012. Alzheimer's Disease Facts and Figures. Available at: http:\/\/www.alz.org\/downloads\/facts_figures_2012.pdf."},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging and Alzheimer's Association workgroup on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3233\/JAD-2009-0968","article-title":"Magnetic resonance imaging improves cerebrospinal fluid biomarkers in the early detection of Alzheimer's disease","volume":"16","author":"Brys","year":"2009","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib4","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.neuroimage.2010.02.064","article-title":"Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative","volume":"51","author":"Chen","year":"2010","journal-title":"NeuroImage"},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib5","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1212\/01.WNL.0000055847.17752.E6","article-title":"Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer's disease?","volume":"60","author":"Ch\u00e9telat","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib6","doi-asserted-by":"crossref","first-page":"e21896","DOI":"10.1371\/journal.pone.0021896","article-title":"Identification of conversion from mild cognitive impairment\u00a0to\u00a0Alzheimer's disease using multivariate predictors","volume":"6","author":"Cui","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib7","first-page":"1625","article-title":"Prediction of individual clinical outcome in MCI by means of genetic assessment and 18F-FDG PET","volume":"46","author":"Drzezga","year":"2005","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib8","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.neurobiolaging.2010.10.019","article-title":"Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarker and neuropsychological test performance","volume":"33","author":"Ewers","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib9","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.20730","article-title":"Inverse relation between in\u00a0vivo amyloid imaging load and cerebrospinal fluid A\u03b242 in humans","volume":"59","author":"Fagan","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s12031-012-9934-y","article-title":"Apolipoprotein \u03b54-allele as a significant risk factor\u00a0for\u00a0conversion from mild cognitive impairment to Alzheimer's disease:\u00a0a meta-analysis of prospective studies","volume":"50","author":"Fei","year":"2013","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib11","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.neurobiolaging.2007.03.029","article-title":"PET imaging of amyloid deposition in patients with mild cognitive impairment","volume":"29","author":"Forsberg","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib12","first-page":"2004","article-title":"The new Alzheimer's criteria in a naturalistic series of patients with mild cognitive impairment","volume":"257","author":"Galluzzi","year":"2010","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib13","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s00259-012-2108-x","article-title":"The prognostic value of amyloid imaging","volume":"39","author":"Gelosa","year":"2012","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib14","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/archgenpsychiatry.2011.96","article-title":"Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's Disease Neuroimaging Initiative","volume":"68","author":"Gomar","year":"2011","journal-title":"Arch. Gen. Psychiat."},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib15","first-page":"125","article-title":"Clinical features and multidisciplinary approaches to dementia care","volume":"4","author":"Grand","year":"2011","journal-title":"J.\u00a0Multidiscip. Healthc."},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib16","doi-asserted-by":"crossref","first-page":"20954","DOI":"10.1073\/pnas.0906053106","article-title":"Subregional neuroanatomical change as a biomarker for Alzheimer's disease","volume":"106","author":"Holland","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jalz.2011.03.004","article-title":"Introduction to the recommendations from the National Institute on Aging and the Alzheimer's Association workgroup on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Jack","year":"2011","journal-title":"Alzheimer Dement."},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib20","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1093\/brain\/awq277","article-title":"Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease","volume":"133","author":"Jack","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib21","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib22","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.neurobiolaging.2009.07.002","article-title":"Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI","volume":"32","author":"Landau","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib23","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/bmj.313.7056.529","article-title":"Family members' attitudes toward telling the patient with Alzheimer's disease their diagnosis","volume":"313","author":"Maguire","year":"1996","journal-title":"Brit. Med. J."},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib24","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jama.2009.1064","article-title":"CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment","volume":"302","author":"Mattsson","year":"2009","journal-title":"J.\u00a0Amer. Med. Assoc."},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2702.2004.00922.x","article-title":"Dementia diagnosis and disclosure: a dilemma in practice","volume":"13","author":"Monaghan","year":"2004","journal-title":"J.\u00a0Clin. Nurs."},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib26","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1212\/WNL.0b013e3181b23564","article-title":"Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study","volume":"73","author":"Okello","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib27","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1007\/s00259-012-2102-3","article-title":"Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET","volume":"39","author":"Ossenkoppele","year":"2012","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib29","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1093\/brain\/awm238","article-title":"\u03b2-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease","volume":"130","author":"Pike","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib30","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1192\/bjp.176.6.514","article-title":"Truth-telling and the diagnosis of dementia","volume":"176","author":"Pinner","year":"2000","journal-title":"Brit. J. Psychiat."},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2174\/156720509788929273","article-title":"Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort","volume":"6","author":"Risacher","year":"2009","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib32","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer's Disease Neuroimaging Initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib33","first-page":"309","article-title":"The experience of research participation and the value of diagnosis in dementia: implications for practice","volume":"7","author":"Smith","year":"1998","journal-title":"J.\u00a0Ment. Health."},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.22248","article-title":"Longitudinal assessment of A\u03b2 and cognition in aging and Alzheimer disease","volume":"69","author":"Villemagne","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib35","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/brain\/awm112","article-title":"3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease","volume":"130","author":"Whitwell","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib36","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/archneurol.2011.3029","article-title":"Comparison of imaging biomarkers in the Alzheimer Disease Neuroimaging Initiative and the Mayo Clinic Study of Aging","volume":"69","author":"Whitwell","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib37","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","article-title":"Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment","volume":"256","author":"Winblad","year":"2004","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib38","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/ana.21598","article-title":"Amyloid imaging in mild cognitive impairment subtypes","volume":"65","author":"Wolk","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib39","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1136\/jnnp-2012-302548","article-title":"Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography","volume":"83","author":"Wolk","year":"2012","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib40","doi-asserted-by":"crossref","first-page":"P485","DOI":"10.1016\/j.jalz.2012.05.1315","article-title":"Brain beta-amyloid deposition and metabolism in early and late mild cognitive impairment","volume":"8","author":"Wu","year":"2012","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib41","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3233\/JAD-2012-120832","article-title":"Enriching amnestic MCI populations for clinical trials: optimal combination of biomarkers to predict conversion to dementia","volume":"32","author":"Yu","year":"2012","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib42","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3174\/ajnr.A1357","article-title":"Fluorodeoxyglucose-positron-emission tomography, single-photon emission tomography, and structural MR imaging\u00a0for prediction of rapid conversion to Alzheimer disease in patients with mild cognitive impairment: a meta-analysis","volume":"30","author":"Yuan","year":"2009","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.neurobiolaging.2013.06.018_bib43","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1467-9868.2005.00503.x","article-title":"Regularization and variable selection via the elastic net","volume":"67","author":"Zou","year":"2005","journal-title":"J.\u00a0R. Statist. Soc. B."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458013002790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458013002790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:21:11Z","timestamp":1759317671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458013002790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0197458013002790"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.06.018","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}